Skip to main content
Canadian Urological Association Journal logoLink to Canadian Urological Association Journal
letter
. 2014 Jul-Aug;8(7-8):230. doi: 10.5489/cuaj.1509

Concerns about renal mass biopsy

Alireza Ghadian 1,
PMCID: PMC4137002  PMID: 25210541

I read with great interest the case report by Abourbih and colleagues.1 In few last decades, the diagnosis of small renal masses (SRMs) has increased due to the routine use of imaging modalities.2 Small renal masses represent 48% to 66% of all renal cell carcinomas and only 1% of them will spread to distant metastasis.3 There is a need to biopsy SRMs to distinguish their behavior by radiologic appearance and to ultimately confirm the diagnosis.4 In the past, the accuracy of the renal mass biopsy (RMB) was disappointing; now, due to improving techniques it is completely appropriate.4,5 Indeed, new minimally invasive treatments for SRMs (such as cryotherapy, high intensity focused ultra-sound and surveillance) made renal mass biopsy more important.5 Also, in some patients suspicious for metastatic lesions in the kidney, we should perform renal mass biopsy before initiating systemic therapy.6

Leveridge and colleagues found that with a new method of computed tomography (CT)-guided renal mass biopsy, the possibility of complications (such as renal hematoma requiring intervention, gross hematuria, pneumothorax, arteriovenous fistula and needle tract seeding) are extremely rare (<1%).7

There are concerns about needle tract seeding. From the 6 reported cases on renal tract seeding after renal mass biopsy, transitional cell carcinoma was the pathology of the tumour in most of them – a contraindication of the renal mass biopsy.5 Moreover, new needle introducers that separate samples from surrounding tissues reduces the probability of seeding and may be why there are no reported cases of seeding after 1993.5

Another concern in renal mass biopsies is the non-diagnostic sample, for which there are solutions:

  1. Using a CT- or ultrasound-guided biopsy.

  2. Using 18-gauge biopsy needles for taking at least 2 samples with 15 to 22 mm length.

  3. Targeting peripheral zones of SRMs (to avoid central zone necrosis).

  4. Inserting the tip of needle with a distance of 2 to 3 mm of outer margin for taking samples from tumour capsule.8

Renal mass biopsies can now be recommended for to diagnose, survey and follow-up SRMs and even it might be able to predict the prognosis of these tumours.

Footnotes

Competing interests: Dr. Ghadian declares no competing financial or personal interests.

References

  • 1.Abourbih S, Aldousari S, Brimo F, et al. Extensive renal infarction following percutaneous biopsy of a small renal mass: A case report. Can Urol Assoc J. 2013;7:E118–20. doi: 10.5489/cuaj.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cooperberg MR, Mallin K, Ritchey J, et al. Decreasing size at diagnosis of stage 1 renal cell carcinoma: Analysis from the National Cancer Data Base, 1993 to 2004. J Urol. 2008;179:2131–5. doi: 10.1016/j.juro.2008.01.097. [DOI] [PubMed] [Google Scholar]
  • 3.Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature. J Urol. 2006;175:425–31. doi: 10.1016/S0022-5347(05)00148-5. [DOI] [PubMed] [Google Scholar]
  • 4.Chatzidarellis E, Skolarikos A, Papatsoris A. To biopsy a small renal mass, or not? Nephrourol Mon. 2012;4:423–4. doi: 10.5812/numonthly.3991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lane BR, Samplaski MK, Herts BR, et al. Renal mass biopsy--a renaissance? J Urol. 2008;179:20–7. doi: 10.1016/j.juro.2007.08.124. [DOI] [PubMed] [Google Scholar]
  • 6.Remzi M, Marberger M. Renal tumor biopsies for evaluation of small renal tumors: Why, in whom, and how? Eur Urol. 2009;55:359–67. doi: 10.1016/j.eururo.2008.09.053. [DOI] [PubMed] [Google Scholar]
  • 7.Leveridge MJ, Finelli A, Kachura JR, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60:578–84. doi: 10.1016/j.eururo.2011.06.021. [DOI] [PubMed] [Google Scholar]
  • 8.Breda A, Treat EG, Haft-Candell L, et al. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: A prospective, blinded study. BJU Int. 2010;105:940–5. doi: 10.1111/j.1464-410X.2009.08989.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Urological Association Journal are provided here courtesy of Canadian Urological Association

RESOURCES